"We are pleased the FDA has accepted our NDA for Bumetanide Nasal Spray," said Benjamin Esque, CEO of Corstasis Therapeutics ...
Jubilant Ingrevia has announced the commissioning of its new cGMP compliant facility at Bharuch, Gujarat. The new facility, which has a capacity of 5,000 metric tonnes, will manufacture nutraceuticals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback